Enforcement Report - Week of April 17, 2024
The share price of Aurobindo Pharma fell in the early trade on April 8 after the company received three observations on its Andhra Pradesh subsidiary.
Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection Due to Presence of White Particles
Enforcement Report - Week of March 27, 2024
FDA Issues Form 483 to Eugia SEZ Private Limited
Eugia`s Generic Sunitinib Malate Receives Approval in the U.S.
Enforcement Report - Week of March 13, 2024
FDA Issues Form 483 to Eugia Pharma Specialities Limited
Only a few weeks after an Eugia manufacturing site in New Jersey received an FDA reprimand, it's set to change hands under a newly revealed transaction.